Oryx International Growth Fund Limited (LON:OIG - Get Free Report) insider Christopher Mills bought 5,000 shares of the business's stock in a transaction that occurred on Wednesday, June 4th. The stock was bought at an average price of GBX 1,123 ($15.25) per share, with a total value of £56,150 ($76,249.32).
Oryx International Growth Fund Price Performance
LON:OIG traded up GBX 47.50 ($0.65) during midday trading on Thursday, hitting GBX 1,170 ($15.89). The company had a trading volume of 3,365 shares, compared to its average volume of 9,590. Oryx International Growth Fund Limited has a 52-week low of GBX 1,000 ($13.58) and a 52-week high of GBX 1,499.97 ($20.37). The stock's fifty day moving average price is GBX 1,083.36 and its 200-day moving average price is GBX 1,114.30. The company has a market capitalization of £170.41 million, a PE ratio of 6.59 and a beta of 0.88. The company has a quick ratio of 11.08, a current ratio of 1.15 and a debt-to-equity ratio of 0.81.
Oryx International Growth Fund Company Profile
(
Get Free Report)
Oryx International Growth Fund Ltd is a closed ended equity mutual fund launched and managed by Harwood Capital LLP. The fund invests in the public equity markets of the United Kingdom and United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in stocks of small and mid cap companies.
Read More
Before you consider Oryx International Growth Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oryx International Growth Fund wasn't on the list.
While Oryx International Growth Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
